Sekisui Chemical (TSE:4204) Stock Revenue Climbs As Cash Flow Cover Tightens

Sekisui Chemical stock closed at ¥2,665 on the day of its Q1 2027 results, after a three month run that left shares up about 13%. The headline this time is not top line growth. It is a quiet squeeze between earnings power and cash generation that matters for dividend investors.

Basic earnings per share for the quarter landed at ¥31.69 and trailing twelve month earnings per share sit at ¥183.21, which underpins a P/E of about 14x. Yet a 3.08% dividend yield is not well covered by free cash flow, which keeps the balance between income and reinvestment firmly in focus.

Is Sekisui Chemical trading at a genuine discount, or just flashing a value signal that the cash flows do not fully support right now? See how the current price, earnings power, and dividend strain line up in our valuation analysis for Sekisui Chemical

Q1 2027 Earnings Summary

• Revenue (Q1 2027 vs Q1 2026): ¥332,970 million vs. ¥305,147 million (up about 9.1%)
• Net Income Excluding Extraordinary Items (Q1 2027 vs Q1 2026): ¥12,793 million vs. ¥13,149 million (down about 2.7%)
• Basic EPS (Earnings Per Share) (Q1 2027 vs Q1 2026): ¥31.69 vs. ¥31.60 (broadly unchanged, up about 0.3%)
• Trailing 12 Month Net Income Excluding Extraordinary Items (Q1 2027 vs Q1 2026): ¥74,818 million vs. ¥71,362 million (up about 4.8%)

If you prefer clean charts to wading through rows of figures and dense commentary, you can view Sekisui Chemical's full financial picture, including a clear look at its dividend track record, in the visual company report for Sekisui Chemical.

Sekisui Chemical’s Growth Story Meets Mixed Evidence

The bullish story around Sekisui Chemical is that capacity expansion in high performance plastics and next generation solar, alongside healthcare and housing, can lift growth and margins while capital returns support per share metrics. Q1 revenue of ¥332,970 million versus ¥305,147 million a year earlier does show the group adding sales rather than merely holding ground, which helps this growth narrative. However, net income excluding extraordinary items slipped from ¥13,149 million to ¥12,793 million and basic EPS was almost flat at ¥31.69 versus ¥31.60. That points to limited early margin progress despite higher volumes.

The longer view is slightly more supportive. Trailing 12 month net income excluding extraordinary items rose from ¥71,362 million to ¥74,818 million, which aligns with the idea of gradual earnings build. Overall, Sekisui Chemical is ticking the revenue and trailing profit boxes, but the evidence of stronger profitability per quarter still looks tentative.

Reveal where the surface looks calm, but the models start to disagree on Sekisui Chemical's path from FY 2027 onward, and see where the consensus might quietly break around the next inflection point with the full analyst estimates for Sekisui Chemical.

Sekisui Chemical Bears Still Waiting For A Clear Crack

The bearish line on Sekisui Chemical is that structural housing weakness, heavy Japan exposure and pressure on plastics margins will cap earnings power even as management talks up higher value products. Q1 results partly lean in that direction. Revenue moved up, yet net income excluding extraordinary items for the quarter slipped and basic EPS was almost unchanged. That looks like volume without clear margin progress, which is exactly what the housing and plastics bears worry about.

At the same time, trailing 12 month net income excluding extraordinary items increased compared with a year earlier. That undercuts the idea that earnings are already rolling over. The latest quarter does not show a break in profitability, but it also does not deliver the kind of step up that would conclusively ease concerns about Japan concentration, regulatory costs in plastics or the need for stronger overseas execution.

Review whether Sekisui Chemical's thin free cash flow cover on a 3.08% dividend is isolated or part of deeper structural issues. Scan the risk analysis for Sekisui Chemical which shows 1 important warning sign.

Stay Ahead With Simply Wall St

If Sekisui Chemical's mix of growing revenue, flat quarterly EPS and a stretched dividend raises questions for you, register for free with Simply Wall St and add it to a Watchlist to track price moves against fair value and watch how the earnings and cash flow story develops. Once you decide to take a position, use the Portfolio Command Center to cut through noise and focus on the most important, stock specific updates that matter for your holdings. For the longer journey, tap into crowd wisdom and real investor debate through the Community to see how others are interpreting new results and risks. That way you can spot potential catalysts or pressure points early and stay a step ahead of the wider market.

Seeking Alternatives Beyond Sekisui Chemical?

Fresh ideas move fast. While the market watches Sekisui Chemical, other potential breakouts and under the radar opportunities may be forming quiet momentum right now. Consider researching options that fit your objectives and risk tolerance.

• Identify potential income-focused companies with strong balance sheets before yields are affected by new demand by scanning the curated 42 dividend fortresses.
• Explore early growth stories where profitability already matters and cash burn is under control by reviewing the hand picked 70 profitable AI stocks that aren't just burning cash.
• Monitor potential compounders with sturdy finances and low risk scores while they may still be less widely followed by checking the focused 58 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com